METASPHERE LABS Aktie

 

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Vancouver, British Columbia – January 13, 2026 - TheNewswire – Metasphere Labs Inc. (“Metasphere” or the “Company”) (CSE: LABZ ) (OTC: LABZF) (FRA: H1N), is pleased to announce a proposed non-brokered private placement (the “Offering”). The Company intends to raise up to $600,000 through the issuance of up to 12,000,000 Units at a price of $0.05 per Unit. Each Unit will consist of one common share in the capital of the Company (the “Common Share”) and one transferable common share purchase warrant (each, a “Warrant”). Each Warrant will entitle the holder to acquire one additional Common Share of the Company at a price of $0.06 for a period of four (4) years from the Closing Date. Net proceeds from the Offering will be used for general working capital and allocation of funds toward general corporate purposes. The Offering is expected to closed on or about January 23, 2026, or on such other date as the Company may determine, subject to the receipt of all required regulatory approval...

  Vancouver, British Columbia – TheNewswire - December 1, 2025 – Metasphere Labs Inc. (“Metasphere” or the “Company”) (CSE: LABZ ) (OTC: LABZF) (FRA: H1N), announces that, due to unfavorable market conditions, the Company has elected to cancel its previously announced  non-brokered private placement offering (the “LIFE Offering”). The LIFE Offering was intended to be conducted under the Listed Issuer Financing Offering under section 5A.2 of National Instrument 45-106 - Prospectus Exemptions, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The LIFE Offering was originally announced on October 17, 2025, and subsequently amended on November 4, 2025 and November 19, 2025. Further details regarding the proposed terms of the LIFE Offering can be found in the Company's prior news releases. The Company continues to evaluate other potential financing opportunities and will provide further updates as appropriate. Abo...

Vancouver, British Columbia – November 19, 2025 - TheNewswire – Metasphere Labs Inc. (“Metasphere” or the “Company”) (CSE: LABZ ) (OTC: LABZF) (FRA: H1N) announces that, further to its news releases dated October 17, 2025 and November 4, 2025, it has filed a second amended offering document dated November 19, 2025 (the “Second Amended Offering Document”). The Second Amended Offering Document supersedes the Company's offering documents dated October 17, 2025, as amended on November 4, 2025, and provides updated disclosure regarding the Offering amount and the use of proceeds. Offering Amount Under the Second Amended Offering Document, the Company is offering a minimum and maximum of 5,000,000 units (“Units”) at a price of $0.09 per Unit for minimum and maximum gross proceeds of $450,000 (the “Offering”). The Offering will not close unless the minimum gross proceeds have been raised. The Company reasonably believes it has sufficient funds to meet its business objectives and liquidi...

Vancouver, British Columbia – November 04, 2025 - TheNewswire – Metasphere Labs Inc. (“Metasphere” or the “Company”) (CSE: LABZ ) (OTC: LABZF) (FRA: H1N), is pleased to announce that further to its news release dated October 17, 2025, the Company will be proceeding with its previously announced listed issuer financing exemption offering on amended terms. Under the amended terms, the Company will offer up to 5,000,000 units of the Company (each, a “Unit”) at a price of $0.09 per Unit for gross proceeds of up to $450,000 (the “Offering”). Each Unit will consist of one common shares in the capital of the Company (each, a “Share”) and one transferable common share purchase warrant (each, a “Warrant”). Each Warrant will entitle the holder to acquire one additional Common Share of the Company at a price of $0.12 at any time on or after 61 days following the closing date in which the Unit is issued (the “Closing Date”) for a period of four years from the Closing Date. The Units u...

Vancouver, British Columbia – October 17, 2025 - TheNewswire – Metasphere Labs Inc. (“Metasphere” or the “Company”) (CSE: LABZ ) (OTC: LABZF) (FRA: H1N), is pleased to announce that it intends to complete the following offerings to raise up to $750,000 in aggregate gross proceeds: Up to 4,347,826 units of the Company (the Units”) at a price of $0.115 per Unit for gross proceeds of up to $500,000 (the “LIFE Offering”); and  Up to 2,173,913 common shares of the Company (the Common Shares”) at a price of $0.115 per Common Share for gross proceeds of up to $250,000 (the “Non-LIFE Offering”).  (collectively, the “Non-Brokered Private Placement”) LIFE Offering The Company intends to raise up to $500,000 through the issuance of up to 4,347,826 Units at a price of $0.115 per Unit. Each Unit will consist of one Common Shares and one transferable common share purchase warrant (each, a “Warrant”). Each Warrant will entitle the holder to acquire one additional Common Share of the...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Vancouver, British Columbia – September 16, 2025 - TheNewswire – Metasphere Labs Inc. (“Metasphere” or the “Company”) (CSE: LABZ ) (OTC: LABZF) (FRA: H1N), is pleased to announce the appointment of Mr. Daniel Xocoyotzin Ontiveros Delgado as chief executive officer (the “CEO”) of the Company, effective September 15, 2025, following the resignation of Mrs. Natasha Ingram from this position. Mr. Ontiveros Delgado is a business professional with global experience—leveraging language fluency to navigate cross-border teams and customers—paired with deep tech and AI expertise and a successful track record in the fintech industry. With experience leading multi-market launches and cross-functional teams, Mr. Ontiveros Delgado bridges strategy and execution to deliver scalable growth and resilient platforms across the blockchain and AI sectors. The Company would like to thank Mrs. Ingram for her contribution to the Company and wishes her continued success in her future endeavors. About Metaspher...

Das Instrument H1N0 CA59140M2076 METASPHERE LABS INC. EQUITY hat seinen ersten Handelstag am 08.08.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument H1N0 CA59140M2076 METASPHERE LABS INC. EQUITY has its first trading date on 08.08.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA2519361000 DevvStream Corp. 07.08.2025 CA2519362099 DevvStream Corp. 08.08.2025 Tausch 10:1 CA59140M1086 Metasphere Labs Inc. 07.08.2025 CA59140M2076 Metasphere Labs Inc. 08.08.2025 Tausch 4:1...